Bent Ejlertsen

22.7k citations

252 papers · 6.4k indexed · 1 hit paper · h-index 44

Impact in

Cancer Research top 0.5%
- Breast Cancer Treatment Studies
Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Risks and Factors

Papers in

Cancer Research 152
- Breast Cancer Treatment Studies 124
- Cancer Genomics and Diagnostics 25
Oncology 162
- HER2/EGFR in Cancer Research 72
- Cancer Treatment and Pharmacology 61

Co-authors: Maj‐Britt Jensen Henning T. Mouridsen Peer Christiansen Ann Knoop Niels Kroman Birgitte Rasmussen Eva Balslev Kirsten Vang Nielsen
Journals: Acta Oncologica (48 papers)Journal of Clinical Oncology (34 papers)Breast Cancer Research and Treatment (24 papers)Cancer Research (20 papers)European Journal of Cancer (15 papers)
Partner nations: Denmark United States United Kingdom

In The Last Decade

Bent Ejlertsen

242 papers receiving 6.3k citations

Hit Papers

align trajectories log scale

The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis 2021 · 189 citations

Peers

Countries citing papers authored by Bent Ejlertsen

Since Specialization

Citations

This map shows the geographic impact of Bent Ejlertsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bent Ejlertsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bent Ejlertsen more than expected).

Fields of papers citing papers by Bent Ejlertsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bent Ejlertsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bent Ejlertsen. The network helps show where Bent Ejlertsen may publish in the future.

Co-authors

The 25 scholars most cited alongside Bent Ejlertsen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bent Ejlertsen Line = papers co-authored together Bent Ejlertsen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Statin Therapy in Early Breast Cancer: The MASTER Trial; A Randomized Phase III, Placebo-Controlled Comparison of Standard (Neo)Adjuvant Therapy Plus Atorvastatin versus Standard (Neo)Adjuvant Therapy Plus Placebo Clinical Epidemiology ·Signe Borgquist, Maj‐Britt Jensen, Cecilie Linea Bendorff, Peer Christiansen, Birgitte Vrou Offersen, Annette Raskov Kodahl, Marianne Ewertz, Anders Bonde Jensen, Thomas P. Ahern, Deirdre Cronin‐Fenton, Bent Ejlertsen	2025	4
2	Comprehensive mapping elucidates high risk genotypes in primary metastatic breast cancer Neoplasia ·Tobias Berg, Lise Barlebo Ahlborn, Maj‐Britt Jensen, Ann Knoop, Bent Ejlertsen, Maria Rossing	2025	0
3	Association between low-dose aspirin use and breast cancer recurrence: a Danish nationwide cohort study with up to 23 years of follow-up British Journal of Cancer ·Elisabeth Solmunde, Rikke Neess Pedersen, Mette Nørgaard, Lene Mellemkjær, Søren Friis, Bent Ejlertsen, Thomas P. Ahern, Deirdre Cronin‐Fenton	2025	0
4	Development and Methodological Validation of a Modified Staging System for de Novo Metastatic Breast Cancer JAMA Network Open ·Tobias Berg, Maj‐Britt Jensen, Maria Rossing, Troels Bechmann, Frede Donskov, Ann Knoop, Bent Ejlertsen	2024	4
5	Prognostic Value of Pretreatment Plasma C-Reactive Protein in Patients with Early-Stage Breast Cancer Cancer Epidemiology Biomarkers & Prevention ·Høgni H. Andersen, Stig E. Bojesen, Julia S. Johansen, Bent Ejlertsen, Tobias Berg, Malgorzata Tuxen, Kasper Madsen, Hella Danø, Henrik Flyger, Maj‐Britt Jensen, Dorte Nielsen	2024	1
6	Multigene profiles to guide the use of neoadjuvant chemotherapy for breast cancer: a Copenhagen Breast Cancer Genomics Study npj Breast Cancer ·Maj‐Britt Jensen, Christina B. Pedersen, Maria-Anna Misiakou, M.-L. M. Talman, L.J. Gibson, U.B. Tange, H. Kledal, Ilse Vejborg, Niels Kroman, Finn Cilius Nielsen, Bent Ejlertsen, Maria Rossing	2023	4
7	Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Study JNCI Journal of the National Cancer Institute ·Søren Cold, Frederik Cold, Maj‐Britt Jensen, Deirdre Cronin‐Fenton, Peer Christiansen, Bent Ejlertsen	2022	57
8	Neither Tumor-Infiltrating Lymphocytes nor Cytotoxic T Cells Predict Enhanced Benefit from Chemotherapy in the DBCG77B Phase III Clinical Trial Cancers ·Elahe Shenasa, Elisabeth Specht Stovgaard, Maj‐Britt Jensen, Karama Asleh, Nazia Riaz, Dongxia Gao, Samuel Leung, Bent Ejlertsen, Anne‐Vibeke Lænkholm, Torsten O. Nielsen	2022	2
9	Tumour-infiltrating CD4-, CD8- and FOXP3-positive immune cells as predictive markers of mortality in BRCA1- and BRCA2-associated breast cancer British Journal of Cancer ·Nanna Jørgensen, Thomas Vauvert F. Hviid, Lise Birk Nielsen, Ida Marie Heeholm Sønderstrup, Jens Ole Eriksen, Bent Ejlertsen, Anne‐Marie Gerdes, Torben A. Kruse, Mads Thomassen, Maj‐Britt Jensen, Anne‐Vibeke Lænkholm	2021	11
10	A careful reassessment of anthracycline use in curable breast cancer npj Breast Cancer ·Sara A. Hurvitz, Nicholas P. McAndrew, Aditya Bardia, Michael F. Press, Mark D. Pegram, John Crown, Peter A. Fasching, Bent Ejlertsen, Eric H. Yang, John A. Glaspy, Dennis J. Slamon	2021	33
11	Early Discontinuation of Endocrine Therapy and Recurrence of Breast Cancer among Premenopausal Women Clinical Cancer Research ·Lindsay J. Collin, Deirdre Cronin‐Fenton, Thomas P. Ahern, Michael Goodman, Lauren E. McCullough, Lance A. Waller, Anders Kjærsgaard, Per Damkier, Peer Christiansen, Bent Ejlertsen, Maj‐Britt Jensen, Henrik Toft Sørensen, Timothy L. Lash	2021	33
12	Survival in Women Diagnosed With Breast Cancer During Pregnancy Clinical Breast Cancer ·Jakob Hansen Viuff, Iben Katinka Greiber, Mona Aarenstrup Karlsen, Lone Storgaard, Niels Kroman, Maj‐Britt Jensen, Simone Eibye, Cristel Sørensen Hjortshøj, Bent Ejlertsen, Jeanette Falck Winther, Susanne K. Kjær, Lene Mellemkjær	2021	5
13	Clinical behavior of recurrent hormone receptor–positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1‐98 clinical trial Cancer ·José Pablo Leone, Bernard F. Cole, Meredith M. Regan, Beat Thürlimann, Alan S. Coates, Manuela Rabaglio, Anita Giobbie‐Hurder, Richard D. Gelber, Bent Ejlertsen, Vernon Harvey, Patrick Neven, István Láng, Hervé Bonnefoi, Andrew Wardley, Aron Goldhirsch, Angelo Di Leo, Marco Colleoni, Inês Vaz-Luís, Nancy U. Lin	2020	5
14	Physical deterioration and adaptive recovery in physically inactive breast cancer patients during adjuvant chemotherapy: a randomised controlled trial Scientific Reports ·Tom Møller, Christina Andersen, Christian Lillelund, Kira Bloomquist, Karl Bang Christensen, Bent Ejlertsen, Malgorzata Tuxen, Peter Oturai, Ulla Breitenstein, Cecilie Kolind, Pernille Travis, Tina Bjerg, Mikael Rørth, Lis Adamsen	2020	33
15	Population-based Study of Prosigna-PAM50 and Outcome Among Postmenopausal Women With Estrogen Receptor-positive and HER2-negative Operable Invasive Lobular or Ductal Breast Cancer Clinical Breast Cancer ·Anne‐Vibeke Lænkholm, Maj‐Britt Jensen, Jens Ole Eriksen, Anne Roslind, Wesley Buckingham, Sean Ferree, Torsten O. Nielsen, Bent Ejlertsen	2020	17
16	Rates of re-excision and conversion to mastectomy after breast-conserving surgery with or without oncoplastic surgery: a nationwide population-based study British journal of surgery ·Erik Heeg, Maj‐Britt Jensen, Lisbet Rosenkrantz Hölmich, Anne Bodilsen, Rob A.�E.�M. Tollenaar, Anne‐Vibeke Lænkholm, Birgitte Vrou Offersen, Bent Ejlertsen, Marc A.M. Mureau, Peer Christiansen	2020	27
17	Forty years of landmark trials undertaken by the Danish Breast Cancer Cooperative Group (DBCG) nationwide or in international collaboration Acta Oncologica ·Bent Ejlertsen, Birgitte Vrou Offersen, Jens Overgaard, Peer Christiansen, Maj‐Britt Jensen, Niels Kroman, Ann Knoop, Henning T. Mouridsen	2017	15
18	High-Risk Premenopausal Luminal A Breast Cancer Patients Derive no Benefit from Adjuvant Cyclophosphamide-based Chemotherapy: Results from the DBCG77B Clinical Trial Clinical Cancer Research ·Torsten O. Nielsen, M. Scharling Jensen, Samantha Burugu, Dongxia Gao, Charlotte L. Tykjaer Jørgensen, Eva Balslev, Bent Ejlertsen	2016	41
19	Obesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 Trial Journal of Clinical Oncology ·Marianne Ewertz, Kathryn P. Gray, Meredith M. Regan, Bent Ejlertsen, Karen N. Price, Beat Thürlimann, Hervé Bonnefoi, John Forbes, Robert Paridaens, Manuela Rabaglio, Richard D. Gelber, Marco Colleoni, István Láng, Ian E. Smith, Alan S. Coates, Aron Goldhirsch, Henning T. Mouridsen	2012	102
20	Prognostic value of Bcl-2 in two independent populations of estrogen receptor positive breast cancer patients treated with adjuvant endocrine therapy Acta Oncologica ·Mathilde Skaarup Larsen, Karsten Bjerre, Anita Giobbie‐Hurder, Anne‐Vibeke Lænkholm, Katrine L. Henriksen, Bent Ejlertsen, Anne E. Lykkesfeldt, Birgitte Rasmussen	2012	18

About Bent Ejlertsen

Bent Ejlertsen is a scholar working on Cancer Research, Oncology, Genetics, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 252 papers that have together received 6.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (124 papers), HER2/EGFR in Cancer Research (72 papers), Cancer Treatment and Pharmacology (61 papers), Estrogen and related hormone effects (57 papers), Advanced Breast Cancer Therapies (48 papers), BRCA gene mutations in cancer (31 papers), Breast Lesions and Carcinomas (26 papers) and Cancer Genomics and Diagnostics (25 papers). The work is most often cited by research in Cancer Research (2.8k citations), Oncology (3.9k citations), Genetics (1.5k citations), Family Practice (95 citations) and Pathology and Forensic Medicine (754 citations). Bent Ejlertsen has collaborated with scholars based in Denmark, United States and United Kingdom. Frequent co-authors include Maj‐Britt Jensen, Henning T. Mouridsen, Peer Christiansen, Ann Knoop, Niels Kroman, Birgitte Rasmussen, Eva Balslev, Kirsten Vang Nielsen, Anne‐Vibeke Lænkholm and Deirdre Cronin‐Fenton. Their work appears in journals such as Acta Oncologica, Journal of Clinical Oncology, Breast Cancer Research and Treatment, Cancer Research and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact